Research use onlyNot for human or veterinary use
ENCORE BIO LABSRESEARCH COLLECTION
KLOW — complete Encore Bio Labs reference vialMATERIAL / 12

Reference artwork · Legacy packaging may be shown.
Listed identity and formats take precedence over the image.

Research material

KLOW

Four components give KLOW a wide range of scientific stories to discover: GHK-Cu, BPC-157, TB-500 and KPV. Research on individual components explores collagen production, cell movement and peptide transport. The interest lies in that variety of questions, with each component's evidence available to examine on its own.

Components
GHK-Cu / BPC-157 / TB-500 / KPV

Formats & reference pricing

USD
Listed formatReference price
80 mg blend$135 USD

Reference prices describe the listed formats. They do not confirm availability or constitute an offer for sale.

Review product documentation

For laboratory research only. Not for human or veterinary use.

A blend name, not a single sequence

KLOW is this catalog's name for a listing with four named components. Two abbreviations can be read chemically: KPV is lysine-proline-valine, while GHK is glycine-histidine-lysine and Cu identifies copper. These component names do not specify the complete blend formula, proportions or the exact TB-500 form.

Catalog component names
GHK-Cu · BPC-157 · TB-500 · KPV
KPV shorthand
Lysine–proline–valine; blend proportions pending

Reference identity only; not a test result for current inventory.

01 / Material overview

The specifications.

Catalog identity
KLOW
Components
GHK-Cu / BPC-157 / TB-500 / KPV
Listed formats
80 mg blend
Reference price range
$135 USD
Intended setting
Qualified laboratory or institutional research
Inventory specifications
Independent inventory review pending

02 / Regulatory context

Regulatory & safety notes.

FDA’s public compounding materials can provide regulatory safety context. They do not verify a current Encore Bio Labs lot.

FDA PUBLIC RECORD · REVIEWED OCT 2026KLOW · GHK-Cu / BPC-157 / TB-500 / KPV

FDA compounding record · KLOW · GHK-Cu / BPC-157 / TB-500 / KPV

FDA's current compounding safety page discusses GHK-Cu, BPC-157, thymosin beta-4 fragment (TB-500), and KPV separately. Those records describe varying immunogenicity, characterization, and data-limit concerns. FDA has not evaluated this catalog blend as a single approved product.

Component-level public records do not establish the exact composition, component quantities, purity, sterility, potency, or suitability of this blend.

FDA record type
Human drug compounding safety context
Human-use guidance
Not provided

03 / Supporting records

Documentation.

Read the Encore summary, the scope of related reports and the status of privacy-redacted supplier copies.

No authenticated certificate establishing current-inventory identity or specifications is published for KLOW in this catalog.

Encore documentary summary · not a laboratory-issued COA

Report availability
3 related reports located
Formats & scope
Related blend reports differ in composition and component quantification.
Report authenticity
Laboratory authentication pending
Inventory evidence review
Report-to-inventory correspondence has not been independently established. No purity, quantity or activity result is attributed to current inventory.
Outstanding review
Resolve exact composition, component amounts and differences between stated and measured totals. Chromatographic peak area is not a quantity in mg.
Product-specific SDS
Not located in the reviewed PDF set; applicability and verification pending.

Document inventory reviewed October 6, 2026. Related reports were commissioned by third parties, not Encore. Original customer details and internal records are not included here.

Privacy-redacted supplier report

Report review pending

Where prepared, these are copies redacted by Encore for privacy, not laboratory-issued public versions or Encore-commissioned tests. Analytical content is not replaced with Encore results.

Copy preparation
3 source files in redacted review copies. Duplicate file formats are not additional tests.
Supplier sharing permission
Owner-confirmed for supplied reports; this does not imply a report exists for every product. Report authentication is a separate check.
Privacy review
Release review pending. Retained references and copies elsewhere can still identify the original customer; redaction does not guarantee anonymity.
Downloads
No website copy released. No download is available for this product.
Laboratory-issued public copy
Not available. Encore-prepared redactions are not an issuer reissue.

Select individual reports for release after reviewing remaining privacy exposure, sample scope and discrepancies. A prepared review packet is not a cleared public copy.

A public copy does not by itself verify current inventory. No laboratory replacement or delivery date is promised.

Explore summary & report status

04 / A closer look

Common questions.

01Which KLOW formats and reference prices are listed?

80 mg blend: $135 USD. These are catalog quantities and reference prices, not usage instructions, stock confirmation or an offer for sale.

02Where can I find the KLOW reports?

Report review pending. The Documentation section on this page lists the reviewed source status and outstanding items for this material. No public PDF is available for this product; an unreleased or missing document is not a certificate of current inventory.

03Does the image establish the contents of a lot?

No. The image is owned Encore Bio Labs reference artwork and may show legacy packaging. Use the written identity and specifications, then verify the exact lot with supporting records.

04How should research suitability be assessed?

Qualified personnel should evaluate material identity, lot-specific records, institutional requirements, and study design. Report review pending. Independent inventory review remains pending, and no product-specific SDS was located in the reviewed set. This catalog provides no personal-use or preparation guidance.